Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Trend-Following Stocks
Momentum stocks
Quality stocks
Undervalued stocks
Yield stocks
Growth stocks
Investment Themes
Financial Data
Europe's family businesses
Water
Sin stocks
The future of mobility
The Cannabis Industry
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Fintechs
The Vegan Market
Boats
Robotics
Hydrogen
Financial Data
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
NovoCure Limited
News
Summary
NVCR
JE00BYSS4X48
NOVOCURE LIMITED
(NVCR)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-06-24 pm EDT
75.60
USD
+7.08%
06/21
NovoCure Enrolls First Patient in Study of Tumor Treating Fields, Keytruda Combination to Treat Lung Cancer
MT
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer
BU
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer
CI
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about NOVOCURE LIMITED
06/21
NovoCure Enrolls First Patient in Study of Tumor Treating Fields, Keytruda Combination ..
MT
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
BU
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
CI
06/06
HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
06/03
Novocure Falls 5%, Zai Lab Rises 8%; Companies Report Study Results
DJ
06/03
NOVOCURE
: Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K
PU
06/03
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
BU
06/03
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
CI
05/26
NOVOCURE
: Announces Clinical Collaboration with MSD on a Registrational-Intent Study to E..
PU
05/26
NovoCure Teams Up With Merck to Study Tumor Treating Fields Combined With Keytruda to T..
MT
05/26
Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to ..
BU
05/26
NovoCure Limited Announces Clinical Collaboration with MSD on a Registrational-Intent S..
CI
05/16
NovoCure's Shares Rise After HC Wainwright Initiates Coverage at Buy
MT
05/16
HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13
Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
More most relevant news
All news about NOVOCURE LIMITED
06/21
NovoCure Enrolls First Patient in Study of Tumor Treating Fields, Keytruda Combination ..
MT
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
BU
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
CI
06/10
NOVOCURE LTD
: Change in Directors or Principal Officers, Amendments to Articles of Inc. o..
AQ
06/06
HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
06/03
Novocure Falls 5%, Zai Lab Rises 8%; Companies Report Study Results
DJ
06/03
Zai Lab, Novocure's Phase 2 Study of Gastric Cancer Combination Therapy Meets Primary E..
MT
06/03
NOVOCURE
: Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K
PU
06/03
NOVOCURE LTD
: Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/03
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
BU
More news
News in other languages on NOVOCURE LIMITED
06/21
NovoCure enrôle le premier patient dans l'étude sur les champs de traitement des tumeur..
06/21
Novocure enrôle le premier patient dans KEYNOTE-B36, une étude pilote sur les champs de..
06/03
L'étude de phase 2 de Zai Lab et Novocure sur la thérapie combinée contre le cancer gas..
06/03
Novocure et Zai Lab annoncent que l'étude pilote de phase 2 EF-31, qui évalue les champ..
05/26
MISE À JOUR SECTORIELLE
: Les actions du secteur de la santé propulsées à la hausse près d..
05/26
MISE À JOUR SECTORIELLE
: Les actions du secteur de la santé en hausse jeudi
05/26
NovoCure s'associe à Merck pour étudier les champs de traitement des tumeurs combinés à..
05/26
NovoCure Limited annonce une collaboration clinique avec MSD dans le cadre d'une étude ..
05/16
Les actions de NovoCure augmentent après que HC Wainwright ait initié une couverture à ..
04/28
La perte nette de NovoCure au 1er trimestre est stable, les revenus augmentent
More news
Analyst Recommendations on NOVOCURE LIMITED
06/06
HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
05/16
HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13
Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
04/04
Evercore ISI Adjusts Price Target for NovoCure to $82 From $62, Maintains In-Line Ratin..
MT
02/08
Loop Capital Starts NovoCure at Buy With $200 Price Target
MT
More recommendations
Press releases
06/21
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
BU
06/10
NOVOCURE LTD
: Change in Directors or Principal Officers, Amendments to Articles of Inc. o..
AQ
06/03
NOVOCURE
: Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K
PU
06/03
NOVOCURE LTD
: Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/03
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
BU
More press releases
Powered by Scoopnest.com
Upcoming event on NOVOCURE LIMITED
07/28/22
Interim 2022 Earnings Release (Projected)
Company calendar
Upcoming sector events
07/19/22
GETINGE AB
: Interim 2022 Earnings Release
07/26/22
MASIMO CORPORATION
: Interim 2022 Earnings Release (Projected)
08/08/22
SHOCKWAVE MEDICAL, INC.
: Interim 2022 Earnings Release
More events
Sector
Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Medical Equipment
Master